vTv Therapeutics Inc.
VTVT
$25.24
$1.747.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.00K | 17.00K | 17.00K | 1.02M | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.00K | 17.00K | 17.00K | 1.02M | 1.00M |
| Cost of Revenue | 6.88M | 3.08M | 2.42M | 2.23M | 11.45M |
| Gross Profit | -6.84M | -3.05M | -2.38M | -1.20M | -10.45M |
| SG&A Expenses | 13.65M | 13.25M | 13.35M | 13.65M | 13.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.83M | 25.64M | 25.07M | 25.20M | 25.00M |
| Operating Income | -29.82M | -25.62M | -25.06M | -24.18M | -24.00M |
| Income Before Tax | -28.38M | -23.87M | -22.90M | -22.61M | -22.61M |
| Income Tax Expenses | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K |
| Earnings from Continuing Operations | -28.38 | -23.87 | -22.90 | -22.71 | -22.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.91M | 4.32M | 4.21M | 4.24M | 4.40M |
| Net Income | -23.47M | -19.56M | -18.69M | -18.46M | -18.31M |
| EBIT | -29.82M | -25.62M | -25.06M | -24.18M | -24.00M |
| EBITDA | -29.78M | -25.57M | -24.98M | -24.09M | -23.91M |
| EPS Basic | -2.94 | -3.12 | -3.01 | -3.00 | -4.11 |
| Normalized Basic EPS | -1.60 | -1.69 | -1.63 | -1.61 | -2.18 |
| EPS Diluted | -2.94 | -3.12 | -3.01 | -3.00 | -4.11 |
| Normalized Diluted EPS | -1.60 | -1.69 | -1.63 | -1.61 | -2.18 |
| Average Basic Shares Outstanding | 32.16M | 25.21M | 25.03M | 24.85M | 20.35M |
| Average Diluted Shares Outstanding | 32.16M | 25.21M | 25.03M | 24.85M | 20.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |